Schedule 13D/A
| Filed by: | TANG CAPITAL MANAGEMENT LLC |
| Total Shares: | 10.0m |
| Subject Company: | Aurinia Pharmaceuticals IncView Complete Ownership History |
| Filed as of Date: | 2025-03-04 |
| Event Date: | 2025-02-28 |
| Overall % Ownership: | 7.3 |
| Perf 1d | Perf 5d | Perf 1m | Perf 6m | Perf 1y | Max Gain | # Days to Max Gain | Max Loss | # Days to Max Loss |
|---|---|---|---|---|---|---|---|---|
| 7.302 | 2.599 | -4.0842 | 48.5149 | 51.8564 | 115 | -10.8911 | 26 |
Reporting Persons
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned | Percent of class |
|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 0 | 10.0m | 0 | 10.0m | 10.0m | 7.3 |
| KEVIN TANG | 0 | 10.0m | 0 | 10.0m | 10.0m | 7.3 |
| TANG CAPITAL PARTNERS, LP | 0 | 5.14m | 0 | 5.14m | 5.14m | 3.7 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0 | 4.39m | 0 | 4.39m | 4.39m | 3.2 |
| TANG CAPITAL PARTNERS III, INC | 0 | 0.50m | 0 | 0.50m | 0.50m | 0.4 |
| TANG CAPITAL PARTNERS IV, INC | 0 | 0 | 0 | 0 | 0 | 0 |
View Original Filing on Edgar's
Raw Filing Contents
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
|
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
|
|
Aurinia Pharmaceuticals Inc.
(Name of Issuer) |
|
Common Shares, no par value
(Title of Class of Securities) |
|
05156V102
(CUSIP Number) |
|
Kevin Tang
4747 Executive Drive, Suite 210 San Diego, CA, 92121 858-200-3830 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
|
02/28/2025
(Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
|
SCHEDULE 13D
|
| CUSIP No. | 05156V102 |
| 1 |
Name of reporting person
TANG CAPITAL MANAGEMENT, LLC
|
||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
|
||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC
|
||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
|
||||||||
| 6 | Citizenship or place of organization
DELAWARE
|
||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
|
||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,029,500.00
|
||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
|
||||||||
| 13 | Percent of class represented by amount in Row (11)
7.3 %
|
||||||||
| 14 | Type of Reporting Person (See Instructions)
OO
|
Comment for Type of Reporting Person:
Tang Capital Management, LLC ("TCM") shares voting and dispositive power over such shares with Tang Capital Partners, LP ("TCP"), Tang Capital Partners International, LP ("TCPI"), Tang Capital Partners III, Inc. ("TCP III") and Kevin Tang. The percentages used herein are based on 137,339,016 Common Shares outstanding as of February 25, 2025, as set forth in the Issuer's Annual Report filed on Form 10-K that was filed with the Securities and Exchange Commission on February 27, 2025.
|
SCHEDULE 13D
|
| CUSIP No. | 05156V102 |
| 1 |
Name of reporting person
KEVIN TANG
|
||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
|
||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC
|
||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
|
||||||||
| 6 | Citizenship or place of organization
UNITED STATES
|
||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
|
||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,029,500.00
|
||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
|
||||||||
| 13 | Percent of class represented by amount in Row (11)
7.3 %
|
||||||||
| 14 | Type of Reporting Person (See Instructions)
IN
|
Comment for Type of Reporting Person:
Kevin Tang shares voting and dispositive power over such shares with TCP, TCPI, TCP III and TCM.
|
SCHEDULE 13D
|
| CUSIP No. | 05156V102 |
| 1 |
Name of reporting person
TANG CAPITAL PARTNERS, LP
|
||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
|
||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC
|
||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
|
||||||||
| 6 | Citizenship or place of organization
DELAWARE
|
||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
|
||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
5,140,591.00
|
||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
|
||||||||
| 13 | Percent of class represented by amount in Row (11)
3.7 %
|
||||||||
| 14 | Type of Reporting Person (See Instructions)
PN
|
Comment for Type of Reporting Person:
TCP shares voting and dispositive power over such shares with TCM and Kevin Tang.
|
SCHEDULE 13D
|
| CUSIP No. | 05156V102 |
| 1 |
Name of reporting person
TANG CAPITAL PARTNERS INTERNATIONAL, LP
|
||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
|
||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC
|
||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
|
||||||||
| 6 | Citizenship or place of organization
DELAWARE
|
||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
|
||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
4,388,909.00
|
||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
|
||||||||
| 13 | Percent of class represented by amount in Row (11)
3.2 %
|
||||||||
| 14 | Type of Reporting Person (See Instructions)
PN
|
Comment for Type of Reporting Person:
TCPI shares voting and dispositive power over such shares with TCM and Kevin Tang.
|
SCHEDULE 13D
|
| CUSIP No. | 05156V102 |
| 1 |
Name of reporting person
TANG CAPITAL PARTNERS III, INC
|
||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
|
||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC
|
||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
|
||||||||
| 6 | Citizenship or place of organization
NEVADA
|
||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
|
||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
500,000.00
|
||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
|
||||||||
| 13 | Percent of class represented by amount in Row (11)
0.4 %
|
||||||||
| 14 | Type of Reporting Person (See Instructions)
CO
|
Comment for Type of Reporting Person:
TCP III shares voting and dispositive power over such shares with TCM and Kevin Tang.
|
SCHEDULE 13D
|
| CUSIP No. | 05156V102 |
| 1 |
Name of reporting person
TANG CAPITAL PARTNERS IV, INC
|
||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
|
||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC
|
||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
|
||||||||
| 6 | Citizenship or place of organization
NEVADA
|
||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
|
||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00
|
||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
|
||||||||
| 13 | Percent of class represented by amount in Row (11)
0 %
|
||||||||
| 14 | Type of Reporting Person (See Instructions)
CO
|
|
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Shares, no par value
|
|
| (b) | Name of Issuer:
Aurinia Pharmaceuticals Inc.
|
|
| (c) | Address of Issuer's Principal Executive Offices:
#140, 14315 - 118 AVENUE, EDMONTON,
ALBERTA, CANADA
, T5L 4S6.
|
|
Item 1 Comment:
This Schedule 13D/A (this "Statement") amends the Schedule 13D (the "Original Schedule 13D") filed on September 12, 2024. Items 2, 3, 5 and 7 of the Statement are hereby amended and supplemented to the extent hereinafter expressly set forth. Except as amended hereby, the original disclosure set forth in the Statement shall remain unchanged. All capitalized terms used and not expressly defined herein have the respective meanings ascribed to such terms in the Original Schedule 13D.
| ||
| Item 2. | Identity and Background | |
| (a) | The information previously provided in response to Item 2 is hereby amended and restated by replacing the text thereof in its entirety with the following:
This Statement is filed by TCM, a Delaware limited liability company that is the general partner of TCP and TCPI; Kevin Tang, a United States citizen; TCP, a Delaware limited partnership engaged in capital management; TCPI, a Delaware limited partnership engaged in capital management; TCP III, a Nevada corporation that is indirectly wholly owned by TCP; and Tang Capital Partners IV, Inc., a Nevada corporation that is indirectly wholly owned by TCP ("TCP IV" and, collectively with TCM, Kevin Tang, TCP, TCPI, and TCP III, the "Reporting Persons"). |
|
| (b) | The address of TCM, Kevin Tang, TCP and TCPI is 4747 Executive Drive, Suite 210, San Diego, CA 92121. The address of TCP III and TCP IV is 5955 Edmond Street, Las Vegas, NV 89118. |
|
| (c) | Kevin Tang is the manager of TCM. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV. |
|
| (d) | During the past five years, none of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
|
| (e) | During the past five years, none of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
|
| (f) | See Item 2(a) above. |
|
| Item 3. | Source and Amount of Funds or Other Consideration | |
Item 3 of the Original Schedule 13D is hereby amended to add the following:
Since September 12, 2024 the Reporting persons have expended an aggregate of approximately $23.5 million to purchase 2,800,000 of the Issuer's Common Shares through the open market. The Common Shares were acquired in the ordinary course of business. |
||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | The information previously provided in response to Item 5 is hereby amended and restated by replacing the text thereof in its entirety with the following:
The information set forth in the cover pages of this Schedule 13D is hereby incorporated by reference into this Item 5. As of the date hereof the Reporting Persons beneficially own an aggregate of 10,029,500 of the Issuer's Common Shares, representing 7.3% of the outstanding shares. |
|
| (b) | See item 5(a) above. |
|
| (c) | Schedule A attached hereto as Exhibit 2 describes all transactions in the Issuer's Common Shares that were effected during the past 60 days by the Reporting Persons. |
|
| (d) | No person other than a Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Shares beneficially owned by the Reporting Persons. |
|
| (e) | Not applicable |
|
| Item 7. | Material to be Filed as Exhibits. | |
Exhibit 1: Joint Filing Agreement by and among the Reporting Persons (as amended).
Exhibit 2: Schedule A: Transactions during the past 60 days. |
||
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|
|
|